Crotalidae polyvalent immune Fab(ovine) - BTG

Drug Profile

Crotalidae polyvalent immune Fab(ovine) - BTG

Alternative Names: Antivenin polyvalent crotalid (Ovine) Fab - BTG; Antivenom CroTAb - BTG; CroFab; Crotalid antivenom CroTAb - BTG

Latest Information Update: 15 Mar 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Protherics
  • Developer BTG
  • Class Fab fragments; Polyvalent snake antivenins
  • Mechanism of Action Snake venom inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Snake venom poisoning

Most Recent Events

  • 09 Mar 2016 BTG completes a prospective trial for Snake venom poisoning in USA
  • 09 Mar 2016 BTG initiates a prospective trial for Snake venom poisoning in USA before March 2016
  • 09 Mar 2016 Therapeutic Trial data and adverse events data from a prospective trial in Snake venom poisoning released by BTG
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top